This inventor holds 3 USPTO granted patents. Top assignees: Ajinomoto Co., Ltd., Other. Active years: 1976-1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chigasaki, JA (1976)
- Yokohama, JP (1984 - 1985)
Company Filing History:

Years Active: 1976-1985
Title: Innovations of Yoshiki Minamoto
Introduction
Yoshiki Minamoto is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of culture media and cell lines. With a total of 3 patents, his work has implications for both research and practical applications in medicine.
Latest Patents
Minamoto's latest patents include a culture medium that utilizes cyclodextrin, which has been found to exhibit minimal cytotoxicity on cell growth. This innovative medium incorporates lipophilic substances, such as unsaturated fatty acids and lipophilic vitamins, to promote cell growth and enhance the productivity of valuable products. Another significant patent involves a process for preparing a continuous and spontaneous human-interferon-producing lymphoblastoid cell line. This process includes transforming human lymphocytes with Epstein Barr Virus and selecting cell lines that produce over 1000 units of interferon per milliliter.
Career Highlights
Throughout his career, Minamoto has worked with prominent companies, including Ajinomoto Co., Ltd. His expertise in biotechnology has allowed him to contribute to advancements in cell culture and interferon production, which are crucial for various medical applications.
Collaborations
Minamoto has collaborated with notable coworkers, including Isao Yamane and Takehiko Tachibana. Their combined efforts have furthered research and development in their respective fields.
Conclusion
Yoshiki Minamoto's innovative work in biotechnology, particularly in culture media and cell line development, showcases his significant contributions to science and medicine. His patents reflect a commitment to advancing research and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile